Trials / Unknown
UnknownNCT04487171
Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 248 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Postpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of this study is to determine the screening prevalence and risk factors of postpartum depression, among women who deliver in fourth hospital in the North of France in the context of the COVID epidemy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | The mothers were administrated three questionnaires, (i) the Edinburgh Postnatal Depression Scale (EPDS), (ii) the State-Trait Anxiety Inventory (STAI-YA), and (iii) the Mother-to-Infant Bonding Scale (MIBS) in two stages, on days 2-3 after delivery and during a phone call between days 25-35. |
Timeline
- Start date
- 2020-07-21
- Primary completion
- 2023-07-01
- Completion
- 2023-08-01
- First posted
- 2020-07-27
- Last updated
- 2023-03-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04487171. Inclusion in this directory is not an endorsement.